View recent articles in Biopharma News
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover »
The biopharma world is here. Endpoints News is an independent news organization, reporting on the »
BioPharm International publishes authoritative information on the science and business of »
News on the biopharmaceutical manufacturing industry, focusing on biologics, technology, upstream »
Breaking news from the biotech, clinical research and pharmaceutical industries. BioSpace is The »
Did Gilead just lower the bar on crucial remdesivir trials for Covid-19? Switching endpoints, amping up trial size stirs analysts' fears -- and hopes 
Revolutionizing the Manufacturing Process for Faster Vaccine and Therapeutic Production 
Sage Therapeutics Slashes 53% of Workforce to Focus Resources on Pipeline 
Researchers Suggest Genetics Might Be Behind Patient Response to COVID-19 
Insulin Makers Eli Lilly and Sanofi Provide Low-Cost Options for Patients During COVID-19 Outbreak 
Biopharma Update on the Novel Coronavirus: April 8 
Myriad Genetics pulls sales forecast as coronavirus disrupts operations 
Amid a pandemic, Roche bets $190M on Arrakis and drugging RNA 
Keytruda nabs another priority review; Quell ties up CAR pact with Hannover Medical School 
Compounding drugs during the pandemic: FDA offers policy clarifications 
Weathering the storm: Another biotech braves Covid-19 in upsized IPO 
FDA needs three more months to review Roche's SMA drug — giving Biogen, Novartis some relief 
Hired and Retired: Management moves in a time of crisis 
FDA delays decision on Roche spinal muscular atrophy drug 
Sage to lay off half of workforce in cost-cutting retrenchment 
Inovio begins first human test of experimental coronavirus vaccine 
GSK and Vir launch collaboration on coronavirus 
Servier acquires Symphogen to pick up oncology pipeline 
Gilead agrees microbiome deal with Second Genome 
Daiichi pays $225m to access gene therapy production platform 
Amgen and Adaptive Team up for Neutralizing Antibody COVID-19 Treatment 
J&J Ramps Up COVID-19 Vaccine R&D 
Elastrin Therapeutics Develops Humanized Antibody to Treat COVID-19-Related Issues 
ProBioGen and Immunogenesis Sign Manufacturing Agreement for Immuno-Oncology Candidate 
Astellas to Collaborate with CytomX to Develop T-Cell Therapies for Cancer Treatment